Exclusive

VW badge blue bonnet

VW Sticking to its Smoking Guns

Electric dreams are no threat to the diesel engine, according to the boss of Volkswagen. Has Matthias Mueller got a cunning long-term plan, or...
egypt nile aerial view

Jewel of the Nile loses its sparkle

Fears for a forsaken Egypt as Africa’s fourth largest economy mirrors a Greek tragedy, threatening trade and jeopardising foreign investment By Darren Parkin NERVOUS investors are...
DNA gene

Sweet gene victory around the corner? Therapeutic advances come rolling in

As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...
Flights Cancelled

MONARCH LATEST: Where did it all go wrong?

Private equity firm which owned the popular airline says the total cost of its collapse will take years to calculate as it stares into...
Brandenburg Gate

The fail of Berlin?

After months of quiet anxiety about trade conditions for the country, the voices of Germany’s business leaders are becoming louder as they believe they...
Adam Bain

Is Twitter falling off its perch?

Departure of Adam Bain may have left social media giant rudderless By Darren Parkin "MR. Bain will remain at Twitter in the coming weeks to assist...
Myanmar Fisherman

Myanmar and World Bank Sign Agreement for Budget Support to Accelerate...

NAY PYI TAW, 18 August 2017 —   The Republic of the Union of Myanmar and the World Bank today signed a US$200 million credit for...
Samsung phone

Is Samsung About To Leave The Mobile Market Wide Open?

Despite record sales and impressive forecasts, the tell-tale signs of a looming crisis within the mobile phone giant are there for all to see… By...
Emma Marcegaglia

The quiet influence over European business

From the factory floor of her father’s steel business, to some of the biggest boardrooms in Europe, the rise and rise of Emma Marcegaglia...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...